The Cooper Companies Overview
- Year Founded
-
1958

- Status
-
Public
- Employees
-
16,000

- Stock Symbol
-
COO

- Investments
-
13
- Share Price
-
$80.84
- (As of Wednesday Closing)
The Cooper Companies General Information
Description
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Contact Information
Website
www.coopercos.comCorporate Office
- 6101 Bollinger Canyon Road
- Suite 500
- San Ramon, CA 94583
- United States
Corporate Office
- 6101 Bollinger Canyon Road
- Suite 500
- San Ramon, CA 94583
- United States
The Cooper Companies Stock Performance
As of 23-Apr-2025, The Cooper Companies’s stock price is $80.84. Its current market cap is $16.2B with 200M shares.
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$80.84 | $79.79 | $69.81 - $112.38 | $16.2B | 200M | 2.02M | $2.09 |
The Cooper Companies Financials Summary
As of 31-Jan-2025, The Cooper Companies has a trailing 12-month revenue of $3.93B.
In Thousands, USD |
TTM 31-Jan-2025 | FY 2024 31-Oct-2024 | FY 2023 31-Oct-2023 | FY 2022 31-Oct-2022 |
---|---|---|---|---|
EV | 21,746,003 | 23,370,509 | 17,916,353 | 16,377,599 |
Revenue | 3,928,500 | 3,895,400 | 3,593,200 | 3,308,400 |
EBITDA | 1,095,300 | 1,071,700 | 885,900 | 878,700 |
Net Income | 415,400 | 392,300 | 294,200 | 385,800 |
Total Assets | 12,222,200 | 12,315,200 | 11,658,900 | 11,492,300 |
Total Debt | 2,539,900 | 2,583,700 | 2,569,200 | 2,763,400 |
The Cooper Companies Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
The Cooper Companies Comparisons
Industry
Financing
Details
The Cooper Companies Competitors (13)
One of The Cooper Companies’s 13 competitors is ICU Medical, a Corporation company based in San Clemente, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ICU Medical | Corporation | San Clemente, CA | ||||
Globus Medical | Formerly VC-backed | Audubon, PA | ||||
Hoya Group | Corporation | Tokyo, Japan | ||||
Philips | Corporation | Amsterdam, Netherlands | ||||
Boston Scientific | Corporation | Marlborough, MA |
The Cooper Companies Patents
The Cooper Companies Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20170231659-A1 | Embryo transfer catheters | Inactive | 13-Feb-2016 | ||
US-20160302828-A1 | Syringe assemblies | Active | 29-Nov-2013 | ||
US-10617445-B2 | Syringe assemblies | Active | 29-Nov-2013 | ||
US-9907572-B2 | Syringe assemblies | Active | 29-Nov-2013 | ||
US-20180146985-A1 | Syringe assemblies | Active | 29-Nov-2013 | A61B17/435 |
The Cooper Companies Signals
The Cooper Companies Investments & Acquisitions (13)
The Cooper Companies’s most recent deal was a Merger/Acquisition with OBP Medical for . The deal was made on 03-May-2021.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
OBP Medical | 03-May-2021 | Merger/Acquisition | Medical Supplies | ||
SightGlass Vision | 01-Jan-2021 | Merger/Acquisition | Therapeutic Devices | ||
WaveShift (Therapeutic Devices) | 01-Jan-2021 | Merger/Acquisition | Therapeutic Devices | ||
SightGlass Vision | 01-Jan-2020 | Corporate | Therapeutic Devices | ||
Soflex Contact Lenses | 06-Sep-2016 | Merger/Acquisition | Accessories |
The Cooper Companies ESG
Risk Overview
Risk Rating
Updated March, 11, 2025
14.77 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile

Healthcare
Industry
of 587
Rank
Percentile

Medical Supplies
Subindustry
of 58
Rank
Percentile

The Cooper Companies Exits (1)
The Cooper Companies’s most recent exit was on 01-Jun-1992 from Hospital Group of America. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Hospital Group of America | 01-Jun-1992 | Completed |
|
The Cooper Companies Affiliates
Subsidiaries (5)
Name | Industry | Location | Year Founded |
---|---|---|---|
WaveShift (Therapeutic Devices) | Palo Alto, CA | 2015 | |
CooperSurgical | Trumbull, CT | 1990 | |
Coopervision Manufacturing Puerto Rico | Juana Diaz, PR | 1985 | |
Generate Life Sciences | Los Angeles, CA | 1977 | |
CooperVision | Victor, NY | 1958 |
The Cooper Companies FAQs
-
When was The Cooper Companies founded?
The Cooper Companies was founded in 1958.
-
Where is The Cooper Companies headquartered?
The Cooper Companies is headquartered in San Ramon, CA.
-
What is the size of The Cooper Companies?
The Cooper Companies has 16,000 total employees.
-
What industry is The Cooper Companies in?
The Cooper Companies’s primary industry is Therapeutic Devices.
-
Is The Cooper Companies a private or public company?
The Cooper Companies is a Public company.
-
What is The Cooper Companies’s stock symbol?
The ticker symbol for The Cooper Companies is COO.
-
What is the current stock price of The Cooper Companies?
As of 23-Apr-2025 the stock price of The Cooper Companies is $80.84.
-
What is the current market cap of The Cooper Companies?
The current market capitalization of The Cooper Companies is $16.2B.
-
What is The Cooper Companies’s current revenue?
The trailing twelve month revenue for The Cooper Companies is $3.93B.
-
Who are The Cooper Companies’s competitors?
ICU Medical, Globus Medical, Hoya Group, Philips, and Boston Scientific are some of the 13 competitors of The Cooper Companies.
-
What is The Cooper Companies’s annual earnings per share (EPS)?
The Cooper Companies’s EPS for 12 months was $2.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »